David Bleakman, Ph.D.
David is an internationally recognized neuroscientist and expert in drug discovery and development who most recently held the position as...
Preclinical Epilepsy Studies
PsychoGenics has exceptional capabilities and experience in preclinical epilepsy research. This neurological disorder is characterized by recurrent and unpredictable seizures,...
Contact
PsychoGenics empowers your program’s best candidate by leveraging superior scientific expertise, robust ingenuity, innovative tools, and the know-how to identify...
Events
Want to learn more about our drug discovery services in person? PsychoGenics might be headed to an event near you!
Preclinical Schizophrenia Studies
Well-Characterized Rodent Models of Schizophrenia We offer various models that provide valuable insights into the cognitive impairments and other...
Biomarker Analysis of Orally Dosed, Dual Active, Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitor, AQU-118, in the Spinal Nerve Ligation (SNL) Rat Model of Neuropathic Pain
Kwan M Y, Choo A, Hanania T, Ghavami A, Beltran J, Shea J, Barboza A, Hu A, Fowler M, Rao...
Phenotypic characterization of recessive gene knockout rat models of Parkinson’s disease
Kuldip D. Dave, Shehan De Silv, Niketa P. Sheth, Sylvie Ramboz, Melissa J. Beck, Changyu Quang, Robert C. Switzer III,...
Therapeutic Areas
At PsychoGenics, we are dedicated to pushing the boundaries of scientific research and drug development in various therapeutic areas within...
Kathleen Kelly
Kathleen has over 30 years of experience in the human resources field, primarily in the media/entertainment sector. Most recently, Kathleen...
Mouse model systems of autism spectrum disorder: Replicability and informatics signature
Kabitzke, P, Morales, D, He, D, Cox, K, Sutphen, J, Thiede, L, Sabath, E, Hanania, T, Biemans, B, Brunner, D....